ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 72 filers reported holding ZAI LAB LTD in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -11.8% | 600 | 0.0% | 0.00% | – |
| Q2 2023 | $17 | -99.3% | 600 | -99.2% | 0.00% | -100.0% |
| Q1 2023 | $2,413 | +44.5% | 72,547 | +33.4% | 0.00% | 0.0% |
| Q4 2022 | $1,670 | -100.0% | 54,400 | -63.3% | 0.00% | -83.3% |
| Q3 2022 | $5,063,000 | -44.4% | 148,032 | -43.6% | 0.01% | 0.0% |
| Q2 2022 | $9,101,000 | +53.9% | 262,416 | +95.1% | 0.01% | +20.0% |
| Q1 2022 | $5,914,000 | +240.9% | 134,486 | +536.5% | 0.01% | +400.0% |
| Q2 2020 | $1,735,000 | +316.1% | 21,129 | +160.9% | 0.00% | – |
| Q1 2020 | $417,000 | +187.6% | 8,100 | +131.8% | 0.00% | – |
| Q4 2019 | $145,000 | +10.7% | 3,495 | -13.7% | 0.00% | – |
| Q3 2019 | $131,000 | +469.6% | 4,051 | +496.6% | 0.00% | – |
| Q2 2019 | $23,000 | -64.6% | 679 | -75.7% | 0.00% | – |
| Q4 2018 | $65,000 | – | 2,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |